Name:
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)
Type:
Synthetic cannabinoid
AKA:
AM-694
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) image
Synthetic substance, no natural derivative
IUPAC Logo
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) image
AM-694, a synthetic cannabinoid, was first synthesized in the early 2010s. It is part of the broader trend in developing synthetic cannabinoids with potent effects. AM-694's introduction reflects the growing interest in synthetic cannabinoids, leading to concerns about its health risks and regulatory measures.
Synthetic Substances Image
AM-694, a synthetic cannabinoid, was developed in the early 2000s. It acts as an upper, producing euphoria and altered perception. Physical impacts include increased heart rate, dilated pupils, and possible hypertension. Short-term use can cause intense psychological effects and anxiety, while long-term use may result in dependence and cognitive issues. Overdose risks include severe psychological distress and potential toxicity. Safe use is uncertain due to limited research. Recent studies focus on its effects on cannabinoid receptors and associated health risks.
N/A
AM-694, a synthetic cannabinoid, affects cannabinoid receptors, producing altered perception and mood. Immediate effects include euphoria and relaxation, while long-term use may lead to cognitive impairments and psychological issues. Research examines its potency and psychological effects.
N/A
AM-694 is a synthetic cannabinoid with no historical or cultural lore, as it is a recent development. It is used recreationally for its psychoactive effects, primarily within the underground drug culture. Its modern significance lies in the debates over synthetic drugs and their regulation. It highlights the conflict between users seeking legal highs and authorities concerned about health and safety. There are no prominent proponents or opponents specifically associated with AM-694, but it is part of the broader discussion on synthetic cannabinoids and their impact on society.
N/A